vs
Astrana Health, Inc.（ASTH）とSeneca Foods Corp（SENEB）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $508.3M、Seneca Foods Corpの約1.9倍）。Seneca Foods Corpの純利益率が高く（8.8% vs 0.7%、差は8.1%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 1.1%）。Seneca Foods Corpの直近四半期フリーキャッシュフローが多い（$22.9M vs $-6.0M）。過去8四半期でSeneca Foods Corpの売上複合成長率が高い（77.1% vs 53.3%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
セネカフーズ社はアメリカ合衆国ニューヨーク州フェアポートに本社を置く食品加工・販売企業で、事業のほぼ全てが食品包装加工に関するものです。2017会計年度には食品包装事業が会社の純売上高の約98%を占め、うち缶詰野菜が65%、果物製品が23%、冷凍果物・野菜が11%、フルーツチップが1%となっています。
ASTH vs SENEB — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $508.3M |
| 純利益 | $6.6M | $44.8M |
| 粗利率 | — | 16.4% |
| 営業利益率 | 1.9% | 11.8% |
| 純利益率 | 0.7% | 8.8% |
| 売上前年比 | 42.9% | 1.1% |
| 純利益前年比 | 184.4% | 205.4% |
| EPS（希薄化後） | $0.12 | $6.48 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $508.3M | ||
| Q3 25 | $956.0M | $460.0M | ||
| Q2 25 | $654.8M | $297.5M | ||
| Q1 25 | $620.4M | $345.8M | ||
| Q4 24 | $665.2M | $502.9M | ||
| Q3 24 | $478.7M | $425.5M | ||
| Q2 24 | $486.3M | $304.7M | ||
| Q1 24 | $404.4M | $162.2M |
| Q4 25 | $6.6M | $44.8M | ||
| Q3 25 | $373.0K | $29.7M | ||
| Q2 25 | $9.4M | $14.9M | ||
| Q1 25 | $6.7M | $601.0K | ||
| Q4 24 | $-7.8M | $14.7M | ||
| Q3 24 | $16.1M | $13.3M | ||
| Q2 24 | $19.2M | $12.7M | ||
| Q1 24 | $14.8M | — |
| Q4 25 | — | 16.4% | ||
| Q3 25 | — | 13.4% | ||
| Q2 25 | — | 14.1% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 9.8% | ||
| Q3 24 | — | 10.1% | ||
| Q2 24 | — | 14.0% | ||
| Q1 24 | — | — |
| Q4 25 | 1.9% | 11.8% | ||
| Q3 25 | 2.0% | 9.0% | ||
| Q2 25 | 3.1% | 7.8% | ||
| Q1 25 | 3.3% | 0.6% | ||
| Q4 24 | 0.1% | 5.1% | ||
| Q3 24 | 5.9% | 5.8% | ||
| Q2 24 | 6.2% | 8.3% | ||
| Q1 24 | 7.5% | 2.5% |
| Q4 25 | 0.7% | 8.8% | ||
| Q3 25 | 0.0% | 6.5% | ||
| Q2 25 | 1.4% | 5.0% | ||
| Q1 25 | 1.1% | 0.2% | ||
| Q4 24 | -1.2% | 2.9% | ||
| Q3 24 | 3.4% | 3.1% | ||
| Q2 24 | 3.9% | 4.2% | ||
| Q1 24 | 3.7% | — |
| Q4 25 | $0.12 | $6.48 | ||
| Q3 25 | $0.01 | $4.29 | ||
| Q2 25 | $0.19 | $2.14 | ||
| Q1 25 | $0.14 | $0.10 | ||
| Q4 24 | $-0.14 | $2.10 | ||
| Q3 24 | $0.33 | $1.90 | ||
| Q2 24 | $0.40 | $1.80 | ||
| Q1 24 | $0.31 | — |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $33.3M |
| 総負債低いほど良い | — | $275.8M |
| 株主資本純資産 | $779.3M | $713.9M |
| 総資産 | $2.2B | $1.2B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.39× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $33.3M | ||
| Q3 25 | $463.4M | $18.1M | ||
| Q2 25 | $342.1M | $12.1M | ||
| Q1 25 | $260.9M | $42.7M | ||
| Q4 24 | $290.8M | $5.3M | ||
| Q3 24 | $350.3M | $9.5M | ||
| Q2 24 | $327.7M | $5.5M | ||
| Q1 24 | $337.3M | $4.5M |
| Q4 25 | — | $275.8M | ||
| Q3 25 | — | $280.2M | ||
| Q2 25 | — | $293.9M | ||
| Q1 25 | — | $369.9M | ||
| Q4 24 | — | $416.2M | ||
| Q3 24 | — | $504.6M | ||
| Q2 24 | — | $572.1M | ||
| Q1 24 | — | $604.8M |
| Q4 25 | $779.3M | $713.9M | ||
| Q3 25 | $775.5M | $672.9M | ||
| Q2 25 | $765.5M | $644.2M | ||
| Q1 25 | $745.4M | $633.0M | ||
| Q4 24 | $712.7M | $612.8M | ||
| Q3 24 | $704.6M | $598.9M | ||
| Q2 24 | $678.9M | $588.9M | ||
| Q1 24 | $653.5M | $582.9M |
| Q4 25 | $2.2B | $1.2B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.3B | $1.2B | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | $1.3B | $1.5B | ||
| Q2 24 | $1.3B | $1.4B | ||
| Q1 24 | $1.2B | $1.4B |
| Q4 25 | — | 0.39× | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.68× | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | — | 1.04× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $31.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $22.9M |
| FCFマージンFCF / 売上 | -0.6% | 4.5% |
| 設備投資強度設備投資 / 売上 | 0.3% | 1.6% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 0.70× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $168.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $31.1M | ||
| Q3 25 | $10.0M | $29.3M | ||
| Q2 25 | $90.9M | $53.7M | ||
| Q1 25 | $16.6M | $91.9M | ||
| Q4 24 | $-10.9M | $117.7M | ||
| Q3 24 | $34.0M | $75.5M | ||
| Q2 24 | $23.2M | $50.3M | ||
| Q1 24 | $6.0M | — |
| Q4 25 | $-6.0M | $22.9M | ||
| Q3 25 | $7.4M | $21.8M | ||
| Q2 25 | $89.5M | $42.4M | ||
| Q1 25 | $13.6M | $81.4M | ||
| Q4 24 | $-13.5M | $108.7M | ||
| Q3 24 | $31.7M | $70.0M | ||
| Q2 24 | $20.4M | $38.3M | ||
| Q1 24 | $5.6M | — |
| Q4 25 | -0.6% | 4.5% | ||
| Q3 25 | 0.8% | 4.7% | ||
| Q2 25 | 13.7% | 14.3% | ||
| Q1 25 | 2.2% | 23.5% | ||
| Q4 24 | -2.0% | 21.6% | ||
| Q3 24 | 6.6% | 16.4% | ||
| Q2 24 | 4.2% | 12.6% | ||
| Q1 24 | 1.4% | — |
| Q4 25 | 0.3% | 1.6% | ||
| Q3 25 | 0.3% | 1.6% | ||
| Q2 25 | 0.2% | 3.8% | ||
| Q1 25 | 0.5% | 3.0% | ||
| Q4 24 | 0.4% | 1.8% | ||
| Q3 24 | 0.5% | 1.3% | ||
| Q2 24 | 0.6% | 4.0% | ||
| Q1 24 | 0.1% | — |
| Q4 25 | -0.44× | 0.70× | ||
| Q3 25 | 26.69× | 0.99× | ||
| Q2 25 | 9.65× | 3.61× | ||
| Q1 25 | 2.48× | 152.87× | ||
| Q4 24 | — | 8.03× | ||
| Q3 24 | 2.11× | 5.68× | ||
| Q2 24 | 1.21× | 3.98× | ||
| Q1 24 | 0.40× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SENEB
| Canned Vegetables | $430.2M | 85% |
| Fruit | $34.6M | 7% |
| Frozen | $29.3M | 6% |
| Manufactured Product Other | $10.8M | 2% |
| Snack | $3.4M | 1% |
